Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Davis C, Carr D. State legal innovations to encourage naloxone dispensing. J Am Pharm Assoc (2003). 2017;57(2):S180-S4.
2. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep 2016;65(1):1-49.
3. U.S. Department of Health and Human Services. HHS recommends prescribing or co-prescribing naloxone to patients at high risk for an opioid overdose. HHS.Gov. December 19, 2018. https://www.hhs.gov/about/news/2018/12/19/hhs-recommends-prescribing-or-co-prescribing-naloxone-to-patients-at-high-risk-for-an-opioid-overdose.html. Accessed 29 Sep 2021.
4. Sohn M, Talbert JC, Huang Z, Lofwall MR, Freeman PR. Association of naloxone coprescription laws with naloxone prescription dispensing in the United States. JAMA Netw Open 2019;2(6):e196215-e.
5. Guy GP, Jr., Haegerich TM, Evans ME, Losby JL, Young R, Jones CM. Vital signs: Pharmacy-based naloxone dispensing - United States, 2012-2018. MMWR Morb Mortal Wkly Rep 2019;68(31):679-86.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献